Discontinued — last reported Q2 '24
JPMorgan Chase Restricted Marketable Securities decreased by 34.2% to $17.70B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 15.3%, from $20.90B to $17.70B. Over 4 years (FY 2020 to FY 2024), Restricted Marketable Securities shows an upward trend with a 113.1% CAGR.
restricted_marketable_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.90B | $24.20B | $30.00B | $34.40B | $43.20B | $33.80B | $31.70B | $27.50B | $23.40B | $29.90B | $20.50B | $13.70B | $22.50B | $20.90B | $26.80B | $26.10B | $26.90B | $17.70B |
| QoQ Change | — | +21.6% | +24.0% | +14.7% | +25.6% | -21.8% | -6.2% | -13.2% | -14.9% | +27.8% | -31.4% | -33.2% | +64.2% | -7.1% | +28.2% | -2.6% | +3.1% | -34.2% |
| YoY Change | — | — | — | — | +117.1% | +39.7% | +5.7% | -20.1% | -45.8% | -11.5% | -35.3% | -50.2% | -3.8% | -30.1% | +30.7% | +90.5% | +19.6% | -15.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.